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Abstract
Most soft tissue sarcomas are characterized by genetic instability and frequent genomic copy number aberrations that are
not subtype-specific. Oligonucleotide microarray-based Comparative Genomic Hybridisation (array CGH) is an important
technique used to map genome-wide copy number aberrations, but the traditional requirement for high-quality DNA
typically obtained from fresh tissue has limited its use in sarcomas. Although large archives of Formalin-fixed Paraffin-
embedded (FFPE) tumour samples are available for research, the degradative effects of formalin on DNA from these tissues
has made labelling and analysis by array CGH technically challenging. The Universal Linkage System (ULS) may be used for a
one-step chemical labelling of such degraded DNA. We have optimised the ULS labelling protocol to perform aCGH on
archived FFPE leiomyosarcoma tissues using the 180k Agilent platform. Preservation age of samples ranged from a few
months to seventeen years and the DNA showed a wide range of degradation (when visualised on agarose gels).
Consistently high DNA labelling efficiency and low microarray probe-to-probe variation (as measured by the derivative log
ratio spread) was seen. Comparison of paired fresh and FFPE samples from identical tumours showed good correlation of
CNAs detected. Furthermore, the ability to macro-dissect FFPE samples permitted the detection of CNAs that were masked
in fresh tissue. Aberrations were visually confirmed using Fluorescence in situ Hybridisation. These results suggest that
archival FFPE tissue, with its relative abundance and attendant clinical data may be used for effective mapping for genomic
copy number aberrations in such rare tumours as leiomyosarcoma and potentially unravel clues to tumour origins,
progression and ultimately, targeted treatment.
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Introduction
Leiomyosarcomas belong to a group of sarcomas that are
characterised by genetic instability as evidenced by pervasive,
seemingly random karyotypic abnormalities. Although the com-
plexity of genomic abnormalities varies significantly among
clinically similar cancer cases, certain aberrations have been
shown to be recurrent and preserved as the tumours evolve.
Accumulating evidence has thus led to the current view that
genetic instability is an enabling characteristic that leads to the
cancer phenotype and that the resulting recurrent copy number
aberrations are an important clue to pathogenetic mechanisms
[1,2]. These recurrent aberrations are believed to result in
amplification or deletion of genes that function to promote or
inhibit respectively, tumour induction and/or progression. In
addition, certain aberrations in remote genomic regions have been
shown to frequently occur simultaneously, suggesting that they
may not be independent events. Some genes in such regions have
been demonstrated to be functionally relevant in major pathways
of oncogenesis, e.g. the ZNF703, DDHD2 and FGFR1 genes at
8p12 and CCND1 at 11q13 that are amplified in breast tumours
[3]. A similar example among sarcomas is the co-amplification of
MDM2, CDK4 and HMGA2 at 12q14, which have recently been
show to occur on separate amplicons in liposarcomas [4].
Mapping of genome-wide copy number aberrations can be
done by microarray-based comparative genomic hybridisation
(array CGH or aCGH). It involves co-hybridising fragments of test
and reference genomic DNA that has been differentially labelled
with fluorescent dyes to a set of mapped and annotated DNA
sequences (probes) on a microarray. By measuring the ratio of
fluorescence at each probe, it is possible to detect copy number
differences between test (tumour) and reference (normal) DNA at
that genomic location. Target probes may be in the form of cDNA
sequences, Bacterial Artificial Chromosomes (BACs) or oligonu-
cleotides and depending on the size, type and number of probes on
the array, copy number aberrations (CNAs) can be detected at the
level of single genes and even specific exons [5]. The highest
resolution aCGH methods available are the oligonucleotide
(60 mers) arrays and with up to a million probes on an array,
CNAs may be detected with a resolution as high as 1–2 Kilobase
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pairs (Kb). Commercially available oligonucleotide CGH arrays
have an added advantage of being easily customisable to focus on
specific areas of the genome [6].
In order to generate reproducible aCGH results, pure high
molecular weight DNA (usually obtained from fresh frozen tissue,
blood or cultured cells) has traditionally been used. Availability of
fresh tissue is however limited, particularly in rare tumours like
leiomyosarcomas and most tumour tissue available for research is
formalin-fixed and paraffin-embedded (FFPE) in order to preserve
the tissue structure for histopathology. DNA isolated from such
tissues is typically of low quality (low yield and low molecular
weight) due to the degradative and fragmenting effects of formalin
[7]. Studies comparing the aCGH performance of high and low
molecular weight DNA showed that fragment sizes ,200 bp
(typical of FFPE DNA) produced noisy and irreproducible results
[8,9].
Another major limitation to the use of FFPE DNA for high-
resolution oligonucleotide aCGH is technical difficulty in labelling
fragmented DNA. Traditional enzymatic methods for labelling
DNA (Nick translation or Random priming) involve a fragmen-
tation step with DNase or restriction digestion respectively, which
in the case of FFPE DNA further fragments the DNA. An
alternative to enzymatic labelling is the Universal Linkage System
(ULS), which directly labels the DNA by a chemical reaction that
incorporates platinum-conjugated fluorophores into DNA without
the need for fragmentation, making it suitable for low molecular
weight DNA such as that from FFPE tissue [10].
Recent efforts have been made to optimise the utility of
archived FFPE tissues for array CGH after labelling by enzymatic
[11] and ULS methods [12,13,14,15,16]. Nevertheless, the use
FFPE DNA for aCGH is still regarded as technically challenging
and limited to very small-scale studies, which have reported
variable array data quality. In this study, we report the
optimisation of the faster, cheaper ULS labelling protocol for
high-resolution oligonucleotide array CGH on the analysis of
archival FFPE leiomyosarcoma tissue using the AgilentH 180K
platform. We were able to compare the quality of the array data
with that from DNA obtained from fresh frozen (FF) samples of
the same tumours, and used Fluorescence In-situ Hybridisation
(FISH) to verify some of the consistent copy number changes.
Materials and Methods
Ethics Statement
National Research Ethics Committee approval was obtained for
the collection and use of fresh and archival tissue samples
(reference numbers 09/H1313/52 and 09/H1313/30, respective-
ly). Written informed consent was obtained before the collection of
fresh tissue samples and all data from archival samples was
analysed anonymously. All tissue was collected and stored
according to the principles of the Declaration of Helsinki and
the use of tissue was in compliance with the Human Tissue Act
2004.
Tumour Samples and Clinical Data
Formalin-fixed, paraffin-embedded (FFPE) samples of tumour
collected between 1997 and 2011 were obtained for 22
Table 1. A summary of FFPE leiomyosarcoma cases included in this study.
Case Anatomical Site Tumour Sampling Date Age of Sample at Analysis DLR Spread
LMS 1 Bowel 2010 1 0.24
LMS 2 Lower Limb 2011 1 0.21
LMS 3 Lower Limb 2011 1 0.17
LMS 4 Bladder 2011 1 0.17
LMS 5 Stomach 2011 1 0.23
LMS 6 Stomach 1994 17 0.25
LMS 7 Lower Limb 1999 12 0.26
LMS 8 Bladder 1998 13 0.21
LMS 91 Vagina 2011 1 0.25
LMS 101 Retroperitoneum 2011 1 0.29
LMS 111 Pelvis 2011 1 0.34
LMS 12 Stomach 2011 1 0.26
LMS 13 Uterus 2004 8 0.40
LMS 14 Bowel 1995 17 0.32
LMS 15 Uterus 1997 15 0.35
LMS 16 Uterus 1997 15 0.33
LMS 17 Nose 1998 14 0.26
LMS 18 Pelvis 2004 8 0.21
LMS 19 Retroperitoneum 2003 9 0.23
LMS 20 Uterus 2008 4 0.21
LMS 21 Uterus 2011 1 0.17
LMS 22 Lower Limb 2000 12 0.27
DLR Spread – Derivative Log Ratio Spread of Array Data.
1 -Additional fresh samples obtained and frozen before fixing in formalin.
doi:10.1371/journal.pone.0050415.t001
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leiomyosarcoma cases (Table 1) from the Histopathology Depart-
ment of the Royal Hallamshire Hospital, Sheffield.
Standard H&E-stained slides representative of tumour blocks
were marked to identify areas of.70% viable tumour, which were
then macro-dissected by scraping off 20 mm sections on glass slides
using a scalpel blade. For three of these cases, prior to fixing in
buffered formalin and within 30 minutes of surgical excision,
tumour and normal tissue (if available) were macroscopically
sampled by an experienced sarcoma pathologist and then snap-
frozen. Array CGH experiments were done on paired fresh frozen
(FF) and FFPE tumour samples. When normal tissue was not
available for sampling, pooled normal genomic DNA (PromegaH)
was used as reference DNA for array CGH experiments.
Genomic DNA Extraction
Genomic DNA was extracted from approximately 25 mg of
fresh frozen tissue (tumour and normal) using the QiagenH
DNeasy Blood and Tissue Kit, according to manufacturer’s
instructions. A modification of the same protocol recommended by
the ULS labelling system manufacturer (AgilentH) was used for
DNA extraction from FFPE tissues. Briefly, approximately 4 mm3
of tissue (the equivalent of two 20 mm-thick sections measuring
10 mm610 mm) was heat de-paraffinised at 90uC, followed by
overnight treatment with 1M-sodium thiocyanate. This was
followed by 48-hour proteinase K treatment and then RNase A
treatment. DNA was then purified using the QiagenH DNeasy kit,
substituting the wash buffer AW2 with 80% ethanol, and eluting in
nuclease–free water.
DNA Quantitation and Quality Assessment
Extracted DNA was quantified by spectrophotometry using a
Nanodrop ND-1000 (NanodropH). Ratios of absorbance, A260/280
and A260/230 were used to assess DNA purity, and samples with
ratios ,1.80 and .1.90, respectively were regarded as sufficiently
pure and suitable for ULS labelling. All DNA samples were
visualized on 1.0% agarose gel pre-stained with Ethidium Bromide
and fragment sizes were assessed against a 1 Kb DNA ladder
(PromegaH).
DNA Labelling
Fresh frozen samples. For fresh frozen samples, an
enzymatic (random priming) labelling system (AgilentH) was used
according to manufacturers’ instructions. Briefly, 0.5–1 mg of
genomic DNA was digested with Alu1 and Rsa1 restriction
enzymes (PromegaH) at 37uC for two hours and then random
primers were added. Tumour and normal DNA samples were
then labelled with Cy5-dUTP and Cy3-dUTP respectively, by
incubation with Exo-Klenow (large fragment of E. coli DNA
polymerase I) at 37uC for a further two hours. Excess nucleotides
were removed using Amicon 30 mm centrifugal filters (MilliporeH).
FFPE samples. FFPE tumour and reference DNA was
labelled using an optimised version of the protocol for ULS
labelling of FFPE DNA (AgilentH). Prior to labelling, heat
fragmentation at 95uC was required when average fragment size
was greater than 7.0 Kb. 0.5–1 mg of tumour and reference DNA
was then chemically labelled by incubating with ULS-Cy5 and
Cy3 respectively (about 1 ml dye for 0.8 mg of DNA) in a thirty-
minute reaction. Labelling reactions were prepared in thin-walled
0.2 ml PCR tubes and incubated on a thermal cycler with a
heated lid (SensoQuestH). Unreacted dye was then removed using
KREApure filters (AgilentH).
Assessment of DNA Labelling Efficiency
Spectrophotometry (Nanodrop ND-2000H) measuring A260 (for
DNA), A550 (for Cy5) and A649 (for Cy3) was used for
determination of DNA and fluorophore concentrations. The
degree of labelling (DoL) is the number of fluorophore molecules
per 100 nucleotides, expressed as a percentage and was calculated
from the post-labelling DNA yield and fluorophore concentration.
According to manufacturer’s recommendations, DoL values
between 0.75% and 2.5% were regarded as optimal for Cy5
while values between 1.75% and 3.5% were optimal for Cy3-
labelled DNA.
Array Hybridisation and Scanning
Cy5-Labeled tumour DNA was combined with an equivalent
amount of Cy3-labeled reference DNA. In five cases, reference
DNA was intentionally sex-mismatched. Repetitive sequences
were blocked with human Cot-1 DNA (InvitrogenH) and samples
were hybridised onto SurePrint G3 Human CGH Microarrays,
46180K (AgilentH) according to manufacturer’s instructions.
Following hybridisation for 24 hours (FF samples) or 40 hours
(FFPE samples), microarray slides were washed according to
manufacturer’s instructions and scanned immediately on a DNA
Microarray Scanner (AgilentH).
Data Analysis
Scanned images were analysed using Feature Extraction
software v10.7.3 (AgilentH), which normalizes the fluorescent
intensity of both dyes at each probe and calculates their ratio,
expressed on a logarithmic scale (probe log2 ratio). It also
computes a set of Quality Control (QC) metrics including the
average green and red signal intensity at all the probes and using
non-hybridising control probes, determines the background signal
(noise) and signal-to-noise ratio. Average signal intensity .150
with signal-to-noise ratio .20 were regarded as satisfactory.
Among other QC metrics, it calculates the Derivative Log Ratio
Spread (DLRS), a measure of the variation in the difference
between log2 ratios of consecutive probes and other quality control
metrics for each array. For paired FF and FFPE DNA samples,
Pearson’s correlations of probe log2 ratios were calculated using
GraphPad Prism Software v5.04 (GraphPadH).
Feature Extracted Data was then analysed using Nexus Copy
Number Software v6.1 (BiodiscoveryH). For individual arrays,
copy number aberrations were called using the FASST2
Segmentation Algorithm, which uses a Hidden Markov Model
(HMM)-based approach that does not aim to estimate the copy
number state at each probe but uses many states to cover more
possibilities, such as mosaic events. These state values are then
used to make calls based on a log2 ratio threshold. Log2 ratio
thresholds 0.25 and20.3 were used to identify single copy number
gains and losses respectively, and thresholds for gains and losses of
two or more copies were set at 1.14 and 21.1 respectively.
Figure 1. Agarose Gel images of DNA extracted from Leiomyosarcoma Tissue. A: DNA extracted from FFPE leiomyosarcoma samples of
different ages (shown in brackets) showing varied degrees of degradation, compared with commercial pooled female genomic DNA. B: Comparison
of DNA extracted from paired FF and FFPE leiomyosarcoma samples (LMS 9, 10 and 11). FF samples show relatively distinct bands of high molecular
weight, while corresponding FFPE samples show low molecular weight fragments in a wide range of sizes. All DNA samples are compared against a
1 Kb DNA ladder. DNA Electrophoresis was done on 1.0% agarose gels were pre-stained with Ethidium Bromide and examined under UV light.
doi:10.1371/journal.pone.0050415.g001
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Significance threshold p-value for aberration calls was set at a
minimum of 5.061026, requiring at least three contiguous probes.
For analysis of common aberrations detected among multiple
samples, the GISTIC (Genomic Identification of Significant
Targets in Cancer) algorithm was used [17]. It was set up to
identify areas of the genome with a statistically high frequency of
aberration with Q-bound value ,= 0.05 and G-score cut-off
,
=1.0,
corrected for multiple testing using False Discovery Rate (FDR)
correction [18]. CNA calls on sex chromosomes were excluded
from analysis.
Fluorescence in situ Hybridisation (FISH)
Two-colour interphase FISH was used to confirm array CGH
results in one of the LMS cases (LMS 9). FISH experiments were
carried out on short-term cultured tumour cells using the LSI
ATM probe (VysisH; SpectrumOrange) and an a-satellite probe to
the centromere of chromosome 11 (VysisH, SpectrumGreen), as
previously described [19].
Results
DNA Quality
The DNA yield in most FFPE LMS tumours was good,
exceeding 10 mg in most cases. In two cases however, the yield was
low and vacuum centrifugation was used to bring DNA
concentration to optimal values. Another FFPE DNA sample
Table 3. Correlation of Probe log2 ratios of paired FF and
FFPE samples of 3 leiomyosarcoma cases.
Correlation LMS 9 LMS 10 LMS 11
Number of Probes 180,880 180,880 180,880
Pearson Coefficient, r 0.59 0.54 20.02
95% Confidence
Interval
0.5830 to 0.5891 0.5365 to 0.5431 20.03 to 20.021
Pearson’s Correlation, r of log2 ratio values of all probes on tumour DNA
samples was calculated using GraphPad Prism software and statistically
significant (p,0.001).
doi:10.1371/journal.pone.0050415.t003
Figure 2. Comparison of Array CGH results in paired Fresh Frozen and Formalin-fixed Paraffin -Embedded samples from LMS 9.
Panel A: Graphical whole-genome views of copy number aberrations (CNAs) identified in both sample types showing close similarities on most
chromosomes. Panel B: Higher resolution graphical views of Chromosome 11 showing the close similarity in gain and loss patterns detected in both
sample types. Panel C: High-resolution views showing the most dissimilar CNA pattern detected between both sample types on chromosome 4. On
Panel A, aberrations called by FASST2 algorithm are represented by blue triangles to the right (amplifications) and red triangles to the left (deletions)
of the chromosomes. Double blue and red triangles/lines represent high-level amplifications and two-copy deletion, respectively. On Panels B and C,
dots represent individual probe log2 ratios plotted as a function of their chromosomal position with a moving average of probe log2 ratios (wavy dark
blue line). Aberration calls are represented by thick black lines with corresponding shaded blue areas above (amplifications) and red areas below
(deletions) the zero line.
doi:10.1371/journal.pone.0050415.g002
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had A260/230,1.50 and the DNA was re-purified by sodium
acetate-isopropanol precipitation before labelling.
When visualized on agarose gels against a 1 Kb ladder, DNA
from the FF samples and commercial pooled genomic DNA
showed relatively distinct bands of high molecular weight DNA,
while that from FFPE tumours showed a range of fragment sizes
that varied from ,1.0 Kb on average to as high as 8.0 Kb. The
degree of fragmentation appeared to be worse in FFPE samples
that were older when compared with the more recent tumours
(Figure 1). Tumour samples presented in this study were chosen to
reflect a wide range of both sample age and degree to DNA
degradation as visualised on agarose gels.
Optimisation of DNA Labelling
Initial attempts at DNA labelling by the ULS method produced
a variable degree of labelling. We noted that when labelling
reactions were carried out on heat blocks or water baths, the
degree of labelling was consistently low and in cases where post-
labelling DNA quantitation showed that there was a higher
amount of DNA in the reaction than initially estimated, the degree
of labelling was either variable or arrays failed due to signal
intensities that were below recommended thresholds. Since the
ULS system does not amplify the DNA, this suggested that the
ratio of DNA to ULS Cy-dye in the reaction was high, resulting in
an inefficient labelling reaction. We therefore modified the
protocol to use excess ULS Cy-dye relative to amount of DNA
(about 0.8 mg of DNA to 1 ml of dye) and carried out reactions in
thin-walled tubes on a thermal cycler to ensure uniform optimal
temperature for the reactions. All FFPE samples that were labelled
in this way had consistently good degree of labelling. Quality
assessment of arrays using this DNA showed good red and green
signal intensity that was similar to that seen with high quality DNA
that was labelled using the enzymatic method. Results of
experiments carried out before and after optimisation of the
labelling protocol are summarised in Table 2.
Array Quality
Signal intensities of both red and green dyes were much higher
than the manufacturer-recommended threshold for all DNA
samples regardless of source tissue or labelling method. The
Derivative Log Ratio Spread (DLRS) is widely regarded as a
robust parameter for measurement of the quality of microarray
Figure 3. Comparison of Array CGH results in paired Fresh Frozen and Formalin-fixed Paraffin -Embedded samples from LMS 10.
Panel A: Graphical whole-genome views of copy number aberrations (CNAs) identified in both sample types showing close similarities on most
chromosomes. Panel B: Higher resolution graphical views of Chromosome 13 showing the close similarity in gain and loss patterns detected in both
sample types. Panel C: High-resolution views showing that even though the CNAs identified by the calling algorithm on chromosome 9 are not
identical, the moving averages of probe log2 ratios in both sample types remain similar. On Panel A, aberrations called by FASST2 algorithm are
represented by blue triangles to the right (amplifications) and red triangles to the left (deletions) of the chromosomes. Double blue and red triangles/
lines represent high-level amplifications and two-copy deletion, respectively. On Panels B and C, dots represent individual probe log2 ratios plotted as
a function of their chromosomal position with a moving average of probe log2 ratios (wavy dark blue line). Aberration calls are represented by thick
black lines with corresponding shaded blue areas above (amplifications) and red areas below (deletions) the zero line.
doi:10.1371/journal.pone.0050415.g003
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experiments. It represents the ‘noisiness’ of array data and a low
DLRS means that the data has small probe-to-probe variability
and better ability to array to identify small aberrations and vice
versa. Manufacturer-recommended thresholds for DLRS when
using FFPE DNA is ,0.4, a value above which array data may be
compromised and the array should be failed. DLRS values for all
the arrays fell in the recommended pass range and all but five of
the 22 FFPE DNA arrays had DLRS ,0.3, the threshold
recommended for DNA from fresh frozen tissue or cells (Table 1).
Comparison of Array CGH on Fresh Frozen vs. FFPE
Tumour DNA
In three LMS cases (LMS 9, 10 and 11), paired samples of
macroscopically sampled fresh tumour and macro-dissected FFPE
tumour were obtained. High molecular weight DNA from the
fresh frozen (FF) tissue was labelled by the enzymatic method,
while fragmented FFPE DNA from the same tumours was labelled
using the one-step ULS method. There was good correlation
between paired FF and FFPE samples in two out of the three cases.
The Pearson correlation coefficients (r) of overall probe log2 ratios
were 0.58 (p,0.0001) and 0.54 (p,0.0001) for LMS 9 and LMS
10 respectively (Table 3).
Genomic profiles of detected CNAs in both sample types were
also were also very similar in both LMS cases with most
chromosomes showing near identical loss and gain patterns
(Figures 2 and 3). One of the most significant differences in CNAs
was seen in LMS 9, where a low level amplification detected on
chromosome 4 in the macro-dissected FFPE sample was not seen
in FF sample (Figure 2C). Similar moving average patterns of
higher amplitude were however retained at the telomeric ends of
4q in both sample types. In both LMS 9 and 10, on most
chromosomes where the aberrations detected by the calling
algorithm were dissimilar, closer examination showed that the
moving average pattern of probe log2 ratios remained similar with
amplitude close to the threshold set in the algorithm for CNA
detection. An example is shown in Figure 3C.
The third leiomyosarcoma case (LMS 11) compared in this way
however, showed poor overall probe log2 ratio correlation
Figure 4. Comparison of Array CGH results in paired Fresh Frozen and Formalin-fixed Paraffin -Embedded samples from LMS 11.
Panel A: Graphical whole-genome views of both sample types showing that majority of the copy number aberrations (CNAs) identified in the macro-
dissected FFPE sample were not detected in the FF sample. Deletions on the long arms of chromosomes 9, 14 and 15 as well as the short arm of
chromosome 16 were the called on both sample types. Panel B: High resolution graphical views of a 6 Mb region along on Chromosome 14
(14q24.1) showing a group of probes with an average log2 ratio of approximately 0.6 and the corresponding single copy amplification detected in the
FFPE sample but no aberrations detected in the FF sample. Panel C: High-resolution graphical views showing a closely similar copy number
aberration detected on Chromosome 15 (15q11.2) in both sample types with similar probe log2 ratios. On Panel A, aberrations called by FASST2
algorithm are represented by blue triangles to the right (amplifications) and red triangles to the left (deletions) of the chromosomes. Double blue and
red triangles/lines represent high-level amplifications and two-copy deletion, respectively. On Panels B and C, dots represent individual probe log2
ratios plotted as a function of their chromosomal position with a moving average of probe log2 ratios (wavy dark blue line). Aberration calls are
represented by thick black lines with corresponding shaded blue areas above (amplifications) and red areas below (deletions) the zero line.
doi:10.1371/journal.pone.0050415.g004
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(r =20.02). Although a few small aberrations were seen in both
sample types, most of the CNAs detected in the macro-dissected
FFPE tissue were not detected in FF tissue (Figure 4). Histological
examination showed that unlike the other two cases, the LMS 11
sample was composed of less than 50% tumour cells with a
significant ad-mixture of normal cells.
Common Aberrations
Most of the tumours showed complex genomic profiles, with
CNAs detected on ten or more chromosomes. Only three cases
had relatively simple genomic profiles. In general, copy number
losses were more common than gains across the entire genome.
The most frequent aberrations (seen in .40% of cases) include
whole or near-whole arm deletion in 10p, 10q, 13q, 16q, and
deletion of the telomeric end of 11q (Figure 5). Deletion in
13q14.2– q14.3 was one of the most frequent focal aberrations
detected and was present in 14 out of 22 (64%) cases. The most
frequent amplification was on 1q21– q23. A number of focal
aberrations correlated very closely with known non-pathological
copy number variations (CNV) or involved non-coding genomic
regions. The frequent deletion in the 11q22 region covering the
locus of the ATM gene was confirmed using Fluorescence in situ
Hybridisation (FISH) in two LMS cases, one on FFPE tissue (not
shown) and the other in cultured cells (Figure 6).
Statistical significance of common aberrations was determined
using the GISTIC algorithm. A G-score is assigned to each
aberrant genomic region based on the frequency and magnitude
(log2 ratio values) of aberrations. It also determines the statistical
probability that the common aberrations occur by chance alone
and using False Detection Rate correction, determines a q-value.
The program also identifies within these regions, ‘peak’ regions
that have the highest statistical likelihood of containing affected
genes (maximal G-score and minimal q-value). Using G-score and
q-value thresholds of 1.0 and 0.05 respectively, we identified five
significant regions of copy number gain covering 331 genes (4
genes in peak region) and seven significant regions of copy number
loss covering 452 genes (13 in peak region), shown in Figure 7.
Discussion
High-resolution mapping of copy number aberrations in cancer
genomes is a valuable way of identifying recurrent genomic
changes. Coupled with epigenetic, expression and functional data,
this can further our understanding of the molecular basis of
cancers and markers can be identified that can be targeted for
tumour diagnosis, prognostic sub-classification or pharmacologic/
biologic therapy [2]. To this end, large-scale projects to catalogue
genomic copy number aberrations in large cohorts of specific
cancers e.g. the Cancer Genome Atlas Project have been
established and over time have yielded important insights in a
number of cancers, including glioblastoma multiforme and
ovarian carcinoma [20,21].
Figure 5. Frequency Plot of Common Genomic Copy Number Aberrations among 22 FFPE Leiomyosarcomas. Commonly aberrant
regions are plotted as a function of their chromosomal position. Red bars to the left of the chromosome represent frequency of deletions and blue
bars to the right of the chromosome represent amplifications. The heights of the bars correspond to the relative frequency of aberrations among the
cases. All CNAs are detected using the FASST2 algorithm.
doi:10.1371/journal.pone.0050415.g005
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Traditionally, such large-scale projects have been designed as
prospective studies and exclusively utilise fresh, frozen tumour
tissue because of the need for high quality DNA for copy number
analysis. Prospective study design is a problem with rare cancers
such as LMS because it would take many years to accumulate
large enough numbers. Tissue fixation in formalin is the standard
procedure in most institutions, and over many years, large FFPE
tissue archives have been accumulated. Such archives are an
essential source of tumour tissue for research and they come
complete with associated clinical data such as disease progression
Figure 6. Two-colour Interphase Fluorescence in situ Hybridisation (FISH) Images of nuclei of cultured leiomyosarcoma cells. Most
cells have five or more chromosome 11 centromere (green signals), but relatively fewer copies of the ATM region 11q22 (red signals) representing
copy number deletion. Nuclei are stained with DAPI (blue). Cells were derived from short-term cultures from fresh tissue (LMS 9).
doi:10.1371/journal.pone.0050415.g006
Figure 7. Statistically-Significant Common Genomic Copy Number Aberrations among 22 FFPE Leiomyosarcomas. Statistically
significance of common aberrations was determined using the GISTIC algorithm. Commonly aberrant regions are plotted along the x-axis as a
function of their chromosomal position and their q-values are plotted on the y-axis on a negative log10 scale so that the highest bars represent most
significant genomic regions. Blue bars represent commonly amplified regions and red bars represent commonly deleted regions. Genomic regions
with G-score .10 and q-values ,0.05 are considered significant (shaded grey) and important candidate genes in these regions e.g. RB1, MYOCD are
shown in black. Aberrations in individual samples were called using FASST2 Algorithm.
doi:10.1371/journal.pone.0050415.g007
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and therapeutic response that can readily be correlated with
molecular genetic data.
Formalin fixation, which is aimed primarily at preserving tissue
protein structure for histopathological studies results in the
formation inter- and intra-strand cross-links between DNA
molecules that results in low yields of highly fragmented nucleic
acids [7]. Other effects such as strand cleavage and base
modifications make PCR amplification of whole genome DNA
prone to bias and errors. As expected, DNA from the FFPE LMS
tumours in this study showed varying degrees of fragmentation
compared to that from FF tissues. The degree of degradation
appeared to be worse with older samples. However, factors such as
pre-fixation and intra-fixation durations and tissue penetration are
known to influence the degree of formalin effects on tissue DNA
[7] and some of the more degraded samples were fixed before
standardised protocols for tissue fixation to preserve their
suitability for molecular studies were widely-established.
Our initial attempts to label FFPE DNA using standard ULS
protocols were not consistently successful. We found that the use of
a thermal cycler with a heated lid gave higher degrees of labelling
than heat blocks or circulating water baths for incubations during
labelling, presumably because the temperature is more uniformly
maintained throughout the labelling reaction. Insufficient dye
amounts relative to DNA were also found to lead to variable or
poor ULS labelling, and even small errors (from user or
equipment) that caused underestimation of DNA concentration
gave poor labelling results. Using an excess of dye relative to DNA
in labelling reactions gave consistent good degree of labelling and
successful arrays. This is in keeping with results published in a
recent study that showed that estimation of DNA concentration is
critical to sample assessment for labelling [22].
Regardless of sample age, all aCGH experiments (FF and FFPE)
in this study showed good DLRS values when labelled using the
modified protocols. In addition, FFPE samples from female
patients that were hybridised against sex-mismatched DNA
showed the X-chromosome gain or loss with log2 ratios near the
expected values, even in cases where there were few other genomic
aberrations. A number of recent studies using FFPE tissues of
similar age have reported variable DLRS values [11,15,16,23]. To
our knowledge however, such consistent good DLRS values have
not been reported from ULS-labelled FFPE DNA.
Two out of three paired FF and FFPE samples from identical
tumours that were compared showed good overall probe log2 ratio
correlation with Pearson’s coefficients similar to those reported
from a similar study [22]. In these two cases, the CNAs detected
across the entire genome in the compared FF and FFPE samples
were also similar. For a few chromosomes where the CNAs
detected by the calling algorithm were dissimilar, visual examina-
tion at a higher resolution showed that in most cases a similar
moving average pattern was retained and the amplitude of average
probe log2 ratios was close to the set thresholds for low-level
aberration detection, thus explaining why aberrations were
differentially called in the two sample types. The calling algorithm
thresholds set for analysis of array CGH data in this study were
chosen based on previous studies in literature and regarded as
valid as they enabled the detection of common aberrations among
the LMS cases that concur with previous studies (see below).
The third case (LMS 11) showed poor statistical correlation of
the overall probe log2 ratios from both sample types and the results
showed that although a few common CNAs were seen, the
majority of CNAs detected in the FFPE sample were not detected
in the FF one. A minority of the genomic regions in LMS 9 and 10
also showed significant difference in the probe moving average
pattern in addition to CNA detected. This prompted a revisit of
the histology of all three tumours, which showed that LMS 11 was
very heterogenous and contained large areas of haematoma and
normal cells, while the former two were composed relatively
homogenously of tumour cells.
In any whole genome nucleic acid isolation, the presence of
germ-line DNA from normal cells ‘contaminating’ a tumour
sample can potentially mask genomic aberrations. Our ability
to macro-dissect tumour cells from the FFPE tissues apparently
helped to reduce the masking of genomic copy number
aberrations. Heterogeneity of tumour cell populations between
the two areas of the whole tumour that were sampled
independently and represented by the FF and FFPE samples
could potentially account for some of the low level differential
aberrations detected in these paired samples in the cases that
looked more homogenous on histological examination.
We carried out common aberration analysis among the
22 FFPE LMS cases in this study. Frequent common aberrations
detected were in concordance with those reported in previous
studies. Deletions on 10q, 13q and 16q have been reported as
frequent among LMS in numerous studies [24,25,26,27]. We have
previously demonstrated a frequent loss on 11q that involves the
locus of the ATM gene that is mirrored in the current study [19]
and confirmed by FISH. Using the GISTIC method, we identified
focal genomic regions with a statistically high frequency of copy
number aberrations over the ‘‘background’’ aberration. Our
results are very similar to those reported by Barretina et al, who
showed deletions on 10p, 10q, 13q, 17p and an amplification on
17p as the most statistically significant common aberrations from
data obtained from fresh frozen tumour samples [28]. The regions
identified contain loci for well-established tumour suppressor and
cell cycle regulatory genes such as PTEN, RB1 and TP53. We also
identified a focal amplification on 17p that specifically covered
most of the MYOCD gene locus that was recently shown to be
frequently amplified and over-expressed in at least one subset of
leiomyosarcomas [29].
Over a quarter of the cases presented in this study showed
CNAs on genomic regions that involve loci for at least three of the
five genes mentioned above, and may well represent a subset of
leiomyosarcoma, although the small number of cases does not
allow any correlation with clinical data to have statistical
significance. The potential for expanding such a retrospective
study to improve its statistical power cannot however, be
overemphasized.
At present, the cost per sample of labelling DNA by the ULS
method is less than that of the enzymatic method. In addition,
DNA labelling and clean-up is complete within one hour,
compared with the enzymatic methods that require at least five
times that duration. Most importantly however, in a 24-month
period that has seen only three operable leiomyosarcoma cases
treated in our centre with the possibility of obtaining fresh tissue,
we have been able to access the FFPE archives and analyse more
than twenty cases for which progression and survival data is
available.
In summary, we have optimised a reliable method that is
cheap, fast and gives us access to long-term archival samples
prepared using even non-standard protocols. We have been
able to generate results from this archival tissue that are in
close concordance with those from multiple previous studies
that utilised fresh tumour tissue. We therefore now have the
option to select specific LMS and other tumour subtypes
including those that are very rare for high-resolution genomic
copy number mapping.
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